Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2008
08/07/2008WO2008094592A1 Hydroxamic acid derivatives of aniline useful as therapeutic agents for treating anthrax poisoning
08/07/2008WO2008094575A2 1-h-pyrazolo(3,4b)pyrimidine derivatives and their use as modulators of mitotic kinases
08/07/2008WO2008094574A2 Furanone compounds and methods of making and using the same
08/07/2008WO2008094571A1 Methods for treating acute and subchronic pain
08/07/2008WO2008094556A2 Imidazolone compounds as tgf-beta family type i receptors, alk5 and/or alk4 antagonists
08/07/2008WO2008094549A1 Fluoroquinolone carboxylic acid salt compositions
08/07/2008WO2008094484A2 Pharmaceutical compositions and methods of using temozolomide and multi-targeted kinase inhibitors
08/07/2008WO2008094479A1 Inhibition of bacterial biofilms with imidazole derivatives
08/07/2008WO2008094476A1 Substituted pyrano [2, 3 - b] pyridine derivatives as cannabinoid -1 receptor modulators
08/07/2008WO2008094473A1 Substituted pyrano[2,3-b]pyridine derivatives as cannabinoid-1 receptor modulators
08/07/2008WO2008094450A1 Treatment of osteoarthritis with omega-3 fatty acids
08/07/2008WO2008094438A1 Macrolactams by engineered biosynthesis
08/07/2008WO2008094379A2 Methods for treatment of pulmonary fibrosis
08/07/2008WO2008094222A2 Porphyrin catalysts and methods of use thereof
08/07/2008WO2008094062A1 Pharmaceutical compositions useful for preventing and treating oncological diseases
08/07/2008WO2008094061A1 Pharmaceutical and cosmetic compositions for accelerated healing of wounds and other surface damages
08/07/2008WO2008094054A2 6, 8-dichlorchroman-3-yl-l, 3-dihydroimidazole-2-thione derivatives and their use for the treatment of cardiovascular disorders
08/07/2008WO2008094053A1 Dosage regimen for comt inhibitors
08/07/2008WO2008094027A1 Use of suramin to prepare a drug for inhibiting retinal and corneal neovascularization
08/07/2008WO2008093984A1 N, n- dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same
08/07/2008WO2008093979A1 Pharmaceutical composition for enhancing sexual activity comprising extracts from rhus verniciflua
08/07/2008WO2008093919A1 Use of n-benzyl-n-(2-dimethylamino-ethyl)benzenesulfonamide derivatives for treating central nervous system disorders
08/07/2008WO2008093878A1 Tablet preparation without causing a tableting trouble
08/07/2008WO2008093855A1 Composition for treatment of undifferentiated-type of gastric cancer
08/07/2008WO2008093853A1 Solid of macrolide compound, method for production thereof, and pharmaceutical composition comprising the same
08/07/2008WO2008093848A1 Composition for decreasing inflammation marker comprising phosphatidylcholine
08/07/2008WO2008093838A1 Pyridyl imidazolidine derivative having sulfamoyl group, and pharmaceutical use thereof
08/07/2008WO2008093826A1 Adiponectin-increasing agent
08/07/2008WO2008093825A1 Caffeine analog
08/07/2008WO2008093793A1 Agent for relief or prevention of xerostomia
08/07/2008WO2008093767A1 Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes
08/07/2008WO2008093764A1 Composition for prevention or treatment of diabetes
08/07/2008WO2008093763A1 Agent for activating or improving neuronal cell or brain function
08/07/2008WO2008093737A1 Amide derivative
08/07/2008WO2008093709A1 Composition for prevention or treatment of disease associated with amyloidosis through inhibition of aggregation amyloid protein and through promotion of degradation of amyloid protein
08/07/2008WO2008093700A1 Trehalose compound, process for production of the compound, and immuno-stimulative agent comprising the compound
08/07/2008WO2008093691A1 Protective agent for retinal nerve or optic nerve
08/07/2008WO2008093686A1 Salt of nonsteroidal anti-inflammatory drug and organic amine compound and use thereof
08/07/2008WO2008093678A1 Hyaluronidase inhibitor
08/07/2008WO2008093677A1 Novel oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibiting activity
08/07/2008WO2008093674A1 Novel thiadiazole derivative having kinase inhibitory activity
08/07/2008WO2008093655A1 Polyalcohol compound and pharmaceutical agent
08/07/2008WO2008093639A1 Pyrazole compound
08/07/2008WO2008093614A1 Novel hepatitis c virus inhibitor
08/07/2008WO2008093495A1 Agent for treatment of multiple sclerosis
08/07/2008WO2008093360A2 A process for preparation of (s)-(+)-n-methyl-3(1-naphthyloxy)-3(2-thienyl)propylamine hydrochloride
08/07/2008WO2008093358A2 Aqueous topical solution containing olopatadine
08/07/2008WO2008093356A1 Pharmaceutical composition for treatment of diabetic complications
08/07/2008WO2008093350A1 Novel anhydrous crystalline form of carvedilol dihydrogen phosphate
08/07/2008WO2008093303A2 Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
08/07/2008WO2008093302A2 Method for decreasing inflammation and oxidative stress in mammals
08/07/2008WO2008093236A1 Tricyclic compounds and their use as glucocorticoid receptor modulators
08/07/2008WO2008093227A1 Tricyclic compounds and their use as glucocorticoid receptor modulators
08/07/2008WO2008093221A2 Pharmaceutical compositions containing pde4 inhibitor for the treatment of inflammatory and allergic disorders
08/07/2008WO2008093194A1 Cannabinoid receptor modulators for treating non-immediate type allergic diseases
08/07/2008WO2008093142A1 Process for the preparation of o-desmethyl venlafaxine
08/07/2008WO2008093086A1 Modulators of hypoxia inducible factor-1 and related uses
08/07/2008WO2008093075A2 5,6,7,8-tetrahydropteridine derivatives as hsp90 inhibitors
08/07/2008WO2008093065A1 L-ALANINE DERIVATIVES AS α5βL ANTAGONISTS
08/07/2008WO2008093064A1 L-ALANINE DERIVATIVES AS α5 BETA 1 ANTAGONISTS
08/07/2008WO2008092987A1 A method for improving the pharmacokinetics of drugs metabolized by ugt2b10
08/07/2008WO2008092954A2 Polymorphic forms of a macrocyclic inhibitor of hcv
08/07/2008WO2008092942A2 Pyridinyl-pyrazole derivatives and their use as potassium channel modulators
08/07/2008WO2008092930A1 Chromene s1p1 receptor antagonist
08/07/2008WO2008092928A2 NOVEL ß-LACTAM ANTIBIOTICS, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF
08/07/2008WO2008092924A1 Enantioselective synthesis of 6-amino-7-hydroxy-4, 5, 6, 7-tetrahydro-imidazo [4, 5, 1-jk] [1] -benzazepin-2 [1h] -one and zilpaterol
08/07/2008WO2008092911A1 Use of adapalene and benzoyl peroxide for the long term treatment of acne vulgaris
08/07/2008WO2008092898A1 Treatment of protein aggregation diseases
08/07/2008WO2008092891A1 1-oxa-3-azaspiro(4.5)decan-2-one derivatives for the treatment of eating disorders
08/07/2008WO2008092888A1 1-oxa-3-azaspiro[4,5]decan--2-one derivatives for the treatment of eating disorders
08/07/2008WO2008092887A1 I-oxa-3-azaspiro (4.5) decan-2-one and 1-oxa-3, 8-diazaspiro (4.5) decan-2-one derivatives for the treatment of eating disorders
08/07/2008WO2008092881A1 New crystal form of cabergoline
08/07/2008WO2008092879A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
08/07/2008WO2008092878A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
08/07/2008WO2008092877A2 8-oxa-1, 4-diazaspiro [4,5] dec-3-en-1-yl and 1,4, 8-triazaspiro [4,5] dec- 3-en-1-yl acetamides as glyti transporter inhibitors in treatment of neurological and neuropsychiatric disorders
08/07/2008WO2008092876A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
08/07/2008WO2008092874A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
08/07/2008WO2008092873A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
08/07/2008WO2008092872A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
08/07/2008WO2008092862A1 Bicyclic derivatives as ep4 agonists
08/07/2008WO2008092861A1 Bicyclic derivatives as ep4 agonists
08/07/2008WO2008092860A1 Bicyclic derivatives as ep4 agonists
08/07/2008WO2008092844A1 Piperidin-acetamide derivatives for the treatment of inflammatory or allergic diseases
08/07/2008WO2008092831A1 Pteridinone derivatives as pi3-kinases inhibitors
08/07/2008WO2008092816A2 Novel polymorphic forms of n-piperidino-5-(4-chlorophenyl)-1(2, 4-dichlorphenyl)-4-methyl-3-pyrazolecarboxamide
08/07/2008WO2008092796A1 Antitumor combination comprising a morpholinyl anthracycline and an antibody
08/07/2008WO2008092786A1 6-oxo-6,7-dihydro-5h-dibenzo[b,d]azepin-7-yl derivatives
08/07/2008WO2008092785A1 Novel 2-aminooxazolines as taar1 ligands for cns disorders
08/07/2008WO2008092690A1 Aminoglycoside antibiotics targeting bacterial 16s ribosomal rna
08/07/2008WO2008092681A1 Ghrelin receptor modulators
08/07/2008WO2008092666A1 Aryl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
08/07/2008WO2008092665A1 Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
08/07/2008WO2008092591A2 Use of guanidinoacetic acid (salts) combined with betaine and/or choline for producing a health-promoting agent
08/07/2008WO2008092576A1 Enrofloxacin-hexahydrate
08/07/2008WO2008092573A1 Novel use of (-)-epigallocatechin gallate
08/07/2008WO2008092466A1 Antiviral combination for treatment of hcv & hbv
08/07/2008WO2008092396A1 Microcapsule formulation of kitasamycin, process for preparation thereof and use thereof
08/07/2008WO2008092352A1 Antitumor compounds and their preparation method
08/07/2008WO2008092335A1 Novel vinblastine derivatives, their preparation, use and pharmaceutical compositions comprising the said derivatives
08/07/2008WO2008092327A1 Half-hydrated crystal of voglibose, the preparation thereof and pharmaceutical composition containing the same
1 ... 3141 3142 3143 3144 3145 3146 3147 3148 3149 3150 3151 3152 3153 3154 3155 3156 3157 3158 3159 3160 3161 ... 7860